New cardiac monitoring system sends AorTech's shares racing
This article was originally published in Clinica
Shares in AorTech, a small UK heart valve manufacturing and distribution company, almost quadrupled in price last week on news that it had acquired the rights to a real-time, continuous output cardiac monitoring catheter.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.